Everolimus
NDC 70954-774, Everolimus, tablet, for suspension, from ANI Pharmaceuticals, Inc..
- Product NDC
- 70954-774
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA220597
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70954-774 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EVEROLIMUS3 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70954-774-20 | 70954077420 | 28 BLISTER PACK in 1 CARTON (70954-774-20) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (70954-774-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/ed7f01b0-3660-4785-a057-a32eea78d64b
Use it
Look up 70954-774 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70954-774 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70954-774. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.